PP53. A quality-adjusted survival (Q-TWIST) analysis of EORTC trial 30853 comparing maximal androgen blockade (MAB) with orchiectomy in patients with metastatic prostate cancer

Authors :: Desmond Curran
JC Weeks
B Cole
KI Rosendahl
LJ Denis
Reginald Hall
Gwendoline M. Kiebert
Source :: European Journal of Cancer. 33:S33-S34
Publication Year :: 1997
Publisher :: Elsevier BV, 1997.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.drug_class
medicine.disease
Androgen
Monoclonal antibody
Blockade
Prostate cancer
Internal medicine
medicine
In patient
Orchiectomy
Quality adjusted survival
business

Full Text Access

Tools